Long-term adjuvant therapy for high-risk GIST: towards tailored imatinib duration?

Ann Oncol. 2024 Dec;35(12):1083-1084. doi: 10.1016/j.annonc.2024.09.019. Epub 2024 Oct 1.
No abstract available

Publication types

  • Editorial